In silico predictions of hERG channel blockers in drug discovery: from ligand-based and target-based approaches to systems chemical biology
O Taboureau, F Steen Jorgensen - Combinatorial Chemistry & …, 2011 - ingentaconnect.com
The risk for cardiotoxic side effects represents a major problem in clinical studies of drug
candidates and regulatory agencies have explicitly recommended that all new drug …
candidates and regulatory agencies have explicitly recommended that all new drug …
In silico predictions of hERG channel blockers in drug discovery: from ligand-based and target-based approaches to systems chemical biology
O Taboureau, FS Jørgensen - … chemistry & high …, 2011 - pubmed.ncbi.nlm.nih.gov
The risk for cardiotoxic side effects represents a major problem in clinical studies of drug
candidates and regulatory agencies have explicitly recommended that all new drug …
candidates and regulatory agencies have explicitly recommended that all new drug …
In silico predictions of hERG channel blockers in drug discovery: from ligand-based and target-based approaches to systems chemical biology.
O Taboureau, FS Jørgensen - Combinatorial Chemistry & High …, 2011 - europepmc.org
The risk for cardiotoxic side effects represents a major problem in clinical studies of drug
candidates and regulatory agencies have explicitly recommended that all new drug …
candidates and regulatory agencies have explicitly recommended that all new drug …
In Silico Predictions of hERG Channel Blockers in Drug Discovery: From Ligand-Based and Target-Based Approaches to Systems Chemical Biology
O Taboureau, FS Sørensen - Combinatorial Chemistry & High …, 2011 - orbit.dtu.dk
The risk for cardiotoxic side effects represents a major problem in clinical studies of drug
candidates and regulatory agencies have explicitly recommended that all new drug …
candidates and regulatory agencies have explicitly recommended that all new drug …